Description

Eterna Peptides presents premium-grade Retatrutide (GLP-3 Architecture) lyophilized powder, supplied in an advanced multi-vial laboratory kit containing 4 single-dose research vials. Functioning as a revolutionary triple mono-agonist, Retatrutide binds concurrently to the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCG) receptors. Its backbone structure is uniquely modified with a custom C20 fatty diacid moiety that optimizes stable albumin binding to drastically extend its metabolic research half-life. Engineered for precision dose-escalation screens and long-duration experimental protocols, these multi-vial presentations serve as an elite investigative tool for tracking triple-incretin receptor activation, high-velocity cellular lipid mobilization, and intensive energy expenditure adaptation without mid-protocol supply degradation.

### Available Kit Configurations (4 Single-Dose Vials Per Kit)
* **Retatrutide 8mg Kit (4 x 2mg Vials):** Calibrated for early-stage baseline metabolic exposure screens and micro-dose kinetic mapping.
* **Retatrutide 16mg Kit (4 x 4mg Vials):** Standardized for mid-tier longitudinal tracking protocols and initial weight management simulation models.
* **Retatrutide 24mg Kit (4 x 6mg Vials):** Engineered for steady-state cellular saturation profiles and multi-subject control groups.
* **Retatrutide 32mg Kit (4 x 8mg Vials):** High-capacity presentation optimized for advanced dose-response tracking and metabolic acceleration assessments.
* **Retatrutide 40mg Kit (4 x 10mg Vials):** Concentrated mass configuration designed for intensive experimental timelines and deep lipid mobilization screens.
* **Retatrutide 48mg Kit (4 x 12mg Vials):** Extended-duration multi-vial setup calibrated for high-velocity cellular metabolic turnover tracking.
* **Retatrutide 56mg Kit (4 x 14mg Vials):** Maximum-capacity presentation optimized for advanced multi-stage protocols and long-term somatotropic axis modeling.

### Mechanism of Action
Retatrutide operates via a unique triple-agonist architecture that yields unparalleled metabolic signaling compared to single or dual incretin mono-therapies:
* **GIP Receptor Path Bias:** Retatrutide acts as a potent full agonist at the GIP receptor network, driving efficient intracellular cyclic AMP ($cAMP$) accumulation to study optimal pancreatic beta-cell insulin secretion dynamics and white adipose tissue repartitioning.
* **GLP-1 Receptor Satiety Alignment:** It acts as a biased agonist at the GLP-1 receptor path, crossing blood-brain barrier boundaries to interface with satiety pathways in the arcuate nucleus, signaling a down-regulation of food-seeking behaviors and appetite drive pathways.
* **Glucagon Receptor Activation & Browning:** Uniquely activating the Glucagon (GCG) receptor, Retatrutide stimulates energy expenditure directly at the cellular level. It is intensively investigated for its ability to increase metabolic rate via white adipose tissue browning kinetics, liver lipid clearance, and enhanced systemic lipid oxidation ($ \beta\text{-oxidation} $).
* **Multi-Vial Protocol Stabilization:** Utilizing isolated single-dose vials across extended timelines prevents repeated puncture degradation and minimizes airborne contaminants, ensuring baseline structural stability throughout long-duration experimental matrices.

### Research Applications
In preclinical and in vitro laboratory models, Retatrutide (GLP-3) multi-vial kits are actively utilized to investigate:
* High-velocity lipid mobilization, visceral adipose tissue browning kinetics, and extreme obesity resistance pathways.
* Pancreatic beta-cell protection, glucose-dependent insulin transcription, and hepatic steatosis clearance metrics.
* Central nervous system satiety pathways, arcuate nucleus neuroplasticity, and behavioral food-seeking motivation curves.
* Precise dose-escalation saturation curves and multi-vial stabilization kinetics over extended timelines.

Our Retatrutide multi-vial kits undergo strict laboratory stabilization, vacuum-drying, and high-purity purification guidelines to ensure absolute peptide chain integrity, rapid reconstitution kinetics, and dependable experimental reproducibility.

—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*